PTC Therapeutics Inc

Common Name
PTC Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
939
Ticker
PTCT
Exchange
NASDAQ/NGS
Description
Ptc Therapeutics Inc. is a biopharmaceutical company engaged in the discovery, development, and commercialization of medicines focusing on rare genetic disorders. The primary objective of Ptc Therapeu...

Financial Statements of PTC Therapeutics

Below are the financial statements of PTC Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD202420232022
Revenues
Net product revenue
600.95a
661.25a
535.23a
Collaboration revenue
0.3a
100.03a
50.05a
Royalty revenue
203.86a
168.86a
113.52a
Manufacturing revenue
1.66a
7.69a
0a
Total revenues
806.78a
937.82a
698.8a
Operating expenses
Cost of product sales, excluding amortization of acquired intangible assets
-57.4a
-65.49a
-44.68a
Amortization of acquired intangible assets
-60.74a
-222.64a
-116.55a
Research and development
-534.48a
-666.56a
-651.5a
Selling, general and administrative
-300.91a
-332.54a
-326a
Change in the fair value of contingent consideration
-4.48a
-127.7a
-25.9a
Intangible asset impairment
-159.55a
-217.8a
-33.38a
Tangible asset impairment and losses (gains) on transactions, net
-0.75a
0a
0a
Total operating expenses
-1,109.35a
-1,377.32a
-1,146.21a
Loss from operations
-302.57a
-439.5a
-447.41a
Interest expense, net
-166.99a
-129.18a
-90.87a
Other income (expense), net
6.54a
10.13a
-49.21a
Gain on sale of priority review voucher
99.9a
0a
0a
Loss on extinguishment of debt
0a
-137.56a
0a
Loss before income tax (expense) benefit
-363.12a
-696.11a
-587.49a
Income tax (expense) benefit
-0.18a
69.51a
28.47a
Net loss attributable to common stockholders
-363.3a
-626.6a
-559.02a

Verified Sources Behind PTC Therapeutics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore PTC Therapeutics’s data sources below and access millions more through our Disclosure Search.

a. PTC Therapeutics's Annual Report 2024
Trace every data point back to PTC Therapeutics’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?